Analysisindustrial chemicalsstepan companyvaluationcash flow
Stepan Company Posts Resilient Cash Flow Outlook
|
3.1
On Feb. 28, 2026, Danny Green’s Substack published a bullish thesis on Stepan Company, noting the stock traded at $66.46 as of Feb. 17 and summarizing Q3 2025 results. Consolidated sales were about $590.3 million, adjusted EBITDA $56.2 million and free cash flow roughly $40.2 million, while GAAP net income fell to $10.8 million; risks center on the Pasadena ramp and feedstock volatility.
Scoring Rationale
Company-level financial update offers actionable allocation guidance, but limited novelty and single-source thesis restrict broader impact.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
